Back to All Events

MASTERMIND: David Roblin (CEO Relation Therapeutics) & Chris Sheldon (Global Head of Business Development GSK): Strategic collaborations  to advance therapeutics for fibrotic disease

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. 

Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise. 

Previous
May 12

reTREAT @ Bio€quity Europe 2025
Next
May 27

The CEO Clinic: Jörn Aldag (Chairman Genespire ) - Navigating the Inflection Point: Scaling Complexity in Life Sciences